Renalytix plc (RNLXY)
↓ Download CSV- Sector Services
- Incorporated X0
- Fiscal year ends Jun 30
In fiscal 2024, Renalytix plc reported revenue of $2.29M, down 32.7% from the prior year. The company ran a net loss, with a net margin of -1461.6% and a gross margin of 6.8%. It held $7.97M in total assets against $15.83M in total liabilities.
Key ratios (FY2024)
6.8%
Gross margin
-1293.5%
Operating margin
-1461.6%
Net margin
-32.7%
Revenue growth (YoY)
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.29M | $3.40M | $2.97M | $1.49M | $0 | — | — |
| Cost of Revenue | $2.13M | $2.68M | $2.10M | $858.0K | $0 | — | — |
| Gross Profit | $156.0K | $720.0K | $874.0K | $633.0K | $0 | — | — |
| Operating Income | -$29.61M | -$42.22M | -$53.18M | -$31.92M | -$10.31M | -$42.34M | — |
| Net Income | -$33.46M | -$45.61M | -$45.28M | -$35.34M | -$9.84M | -$42.30M | — |
| EPS (Diluted) | $-0.31 | $-0.55 | $-0.67 | $-0.49 | $-0.17 | — | — |
| Total Assets | $7.97M | $30.63M | $50.06M | $78.58M | $20.88M | $9.70M | $115.0K |
| Total Liabilities | $15.83M | $23.66M | $19.46M | $7.12M | $4.97M | $1.15M | $617.0K |
| Shareholders' Equity | -$7.85M | $6.97M | $30.61M | $71.46M | $15.91M | $8.55M | -$502.0K |
| Cash & Equivalents | $4.68M | $24.68M | $41.33M | $65.13M | $13.29M | $8.20M | $82.0K |
| Operating Cash Flow | -$30.11M | -$34.09M | -$45.92M | -$28.40M | -$9.52M | -$6.16M | — |
| Capital Expenditures | — | $0 | $557.0K | $773.0K | $804.0K | $309.0K | — |
| Shares Outstanding | 154.37M | 93.78M | 74.76M | 72.20M | 59.42M | 53.82M | 20.00M |